Company · CIK 0001787297 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Passage BIO, Inc. · PASG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2026 PForm 4 → | Jun 29, 4:30 pm EDT | Lynx1 Capital Management LP +110% Owner | 50,055 | $4.12 | $206,101 | 673,759 | +8.03% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.